Home/Pipeline/Albuterol Sulfate Inhalation Aerosol

Albuterol Sulfate Inhalation Aerosol

Bronchospasm

MarketedGeneric (Launched)

Key Facts

Indication
Bronchospasm
Phase
Marketed
Status
Generic (Launched)
Company

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals' mission is to develop, manufacture, and market essential, high-barrier-to-entry pharmaceuticals, with a strategic focus on complex generics, proprietary products, and biosimilars. The company has achieved significant recognition, including an FDA Drug Shortage Assistance Award for its subsidiary, and commercial success with market-leading products like BAQSIMI® nasal glucagon. Its strategy leverages a fully integrated operational model, combining proprietary technology platforms in drug delivery with a diversified portfolio targeting endocrinology, pulmonology, and nephrology to drive sustainable growth.

View full company profile